NCT00368992 2015-09-14S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Completed110 enrolled 8 charts